Active

SCALE I

Switched

BE0675860465

Rechtspersoon Public limited company 1 establishment

Kantersteen 10, 1000 Brussel

Active for

9 year, 3 months

Financials

Financial year 2025

Gross margin

€ -43,828

▼ 26% vs 2024

Profit

Growing

€ 651,221

▲ 322% vs 2024

Debts

Low

€ 281,195

▲ 38815% vs 2024

SCALE I from Brussel, company number BE0675860465, closed financial year 2025 with a result of € 651,221 after tax. For that financial year SCALE I recorded a gross margin of € -43,828 and equity of € 662,782. Compared with financial year 2024, the result moved from € -293,555 to € 651,221. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What happened at SCALE I?

What happened at SCALE I in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Hugues WILLIAMSON stepped down as director. NBB
  • Finance & Invest.Brussels SA stepped down as director. NBB
  • 50° North Ventures SA stepped down as director. NBB
  • Sambrinvest Spin-Off / Spin-Out SA stepped down as director. NBB
  • Be Angels Capital SRL stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 651,221. Source: NBB ↗
  • Hugues WILLIAMSON became a director. NBB
  • Finance & Invest.Brussels SA became a director. NBB

In short

From € 812,337 profit in 2021 to € 651,221 profit in 2025.

Best year ever: 2021, with € 812,337 profit.

Original PDFs at the National Bank ↗

A new publication or filing at SCALE I? We notify you, reason included.

Follow SCALE I

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Sambrinvest Spin-Off / Spin-Out SA 30%
Finance & Invest.Brussels SA 20%
SCALE I
Aquilon Pharmaceuticals 3.4%

The shares are held by Sambrinvest Spin-Off / Spin-Out SA (30%) and Finance & Invest.Brussels SA (20%). It owns 3.4% of Aquilon Pharmaceuticals itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Hugues WILLIAMSON

Director

Also active at: MAYIO

since 2023 · until 2029

Finance & Invest.Brussels SA

Director · represented by Barbara ROOSE

Also active at: BRUXELLES INFRASTRUCTURE FINANCE - BRUSSEL INFRASTUCTUUR FINANCIERING, BRUSERVICES, S.F.A.R. +19 more

since 2023 · until 2029

50° North Ventures SA

Director · represented by André OSTACHKOV

Also active at: EEBIC, BE ANGELS, Brussels South Charleroi BioPark Dev +18 more

since 2023 · until 2029

Sambrinvest Spin-Off / Spin-Out SA

Director · represented by Xavier DAIVE

Also active at: BE ANGELS, Brussels South Charleroi BioPark Dev, 50°NORTH VENTURES +30 more

since 2023 · until 2029

Be Angels Capital SRL

Director · represented by Claire MUNCK

Also active at: SCALE II

since 2023 · until 2029

Shareholders

Sambrinvest Spin-Off / Spin-Out SA

30%

Finance & Invest.Brussels SA

20%

Participations

Aquilon Pharmaceuticals

3.4%

Establishments

Establishment units

Physical locations of this company

Registered office

Kantersteen 10

1000 Brussel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 17 companies are registered at this address.

NELLY

promotion entreprenariat digital bruxellois

EUROPEAN STARTUP NETWORK

Open Collective Brussels

ALTEREDUCS

+12 more

Details

Company number
0675.860.465
VAT number
BE 0675.860.465
Registered office
Kantersteen 10, 1000 Brussel
Names & denominations
SCALE I
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
19 May 2017
Peppol
Not registered
View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What is the enterprise number of SCALE I?
The enterprise number of SCALE I is BE0675860465.
What is the address of SCALE I?
The registered office of SCALE I is located at Kantersteen 10, 1000 Brussel.
When was SCALE I founded?
SCALE I was founded on 19 May 2017.
Does SCALE I have a website?
No website is currently known for SCALE I.
How much profit did SCALE I make in 2025?
SCALE I posted a profit after taxes of € 651,221 in financial year 2025.
What is the revenue of SCALE I?
As a small company, SCALE I is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -43,828.
Where can I find the annual accounts of SCALE I?
SCALE I files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of SCALE I?
According to the 2025 annual accounts, the directors of SCALE I are: Hugues WILLIAMSON, Finance & Invest.Brussels SA, 50° North Ventures SA, Sambrinvest Spin-Off / Spin-Out SA, Be Angels Capital SRL.
Who owns SCALE I?
The shares are held by Sambrinvest Spin-Off / Spin-Out SA (30%) and Finance & Invest.Brussels SA (20%). It owns 3.4% of Aquilon Pharmaceuticals itself.
Who are the shareholders of SCALE I?
According to the 2025 annual accounts, the shareholders of SCALE I are: Sambrinvest Spin-Off / Spin-Out SA (30%), Finance & Invest.Brussels SA (20%).